# Qilu Antibiotics Pharmaceutical Co. , Ltd., Jinan, China – FDA Inspections

Source: https://www.keypedia.com/companies/qilu-antibiotics-pharmaceutical-co-ltd/f1c696c7-317f-4fb9-92a1-df8381af004c

> Inspection records and compliance data for Qilu Antibiotics Pharmaceutical Co. , Ltd. in Jinan. 5 FDA inspections on record, 2 Form 483s, last inspected July 16, 2026.

---

## Details

- Name: Qilu Antibiotics Pharmaceutical Co. , Ltd.
- FEI Number: 3009831352
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: No 849, Licheng District
- City: Jinan
- Country Name: China
- Address: No 849, Licheng District, Jinan, China
- Country: China

## Related Documents

- [FDA Inspection 1333262 - Qilu Antibiotics Pharmaceutical Co. , Ltd. - 2026-07-16](https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/7d9d4743-875c-4992-a37a-35fe116bf9bf) — source: FDA, date: July 16, 2026
- [483 - Qilu Antibiotics Pharmaceutical Co. , Ltd. - 2023-05-30](https://www.keypedia.com/records/483/qilu-antibiotics-pharmaceutical-co-ltd/ea74fdfa-9617-4364-b095-fabb92116823) — source: FDA, date: May 30, 2023
- [FDA Inspection 1210065 - Qilu Antibiotics Pharmaceutical Co. , Ltd. - 2023-05-30](https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/8aa0dc2a-11f5-467c-8d7a-3d6b0a405998) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 30, 2023
- [483 - Qilu Antibiotics Pharmaceutical Co. , Ltd. - 2021-04-26](https://www.keypedia.com/records/483/qilu-antibiotics-pharmaceutical-co-ltd/2d6fdeb5-e3e2-479b-b716-137aae6b5847) — source: FDA, date: April 26, 2021
- [FDA Inspection 1067678 - Qilu Antibiotics Pharmaceutical Co. , Ltd. - 2018-08-16](https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/3c041f5a-2a6c-4c99-8b5b-11e9ce5a735c) — classification: No Action Indicated (NAI), source: FDA, date: August 16, 2018
- FDA Inspection 945452 - Qilu Antibiotics Pharmaceutical Co. , Ltd. - 2015-09-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2015
- FDA Inspection 851836 - Qilu Antibiotics Pharmaceutical Co. , Ltd. - 2013-09-20 — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2013

## Related Companies

- [Latina Pharma S.p.A.](https://www.keypedia.com/companies/latina-pharma-spa/9cb7e758-39a0-4b4c-bfad-93d1468f5d38)
- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/9d02bb1e-32f9-45c5-9b90-f52622553c63)
- [Nordmark Arzneimittel GMBH & Co. KG](https://www.keypedia.com/companies/nordmark-arzneimittel-gmbh-co-kg/871eb270-8517-4646-923a-b4d2eb0ea73b)
- [ALK-Abello, Inc.](https://www.keypedia.com/companies/alk-abello-inc/b626f86d-b379-45aa-96d2-0661e9d1c981)
- [Anhui Poly Pharm. Co., Ltd.](https://www.keypedia.com/companies/anhui-poly-pharm-co-ltd/e1d9c61f-37b4-4759-8c00-51c6d0b78d3b)
- [Shanghai Henlius Biopharmaceuticals Co., Ltd.](https://www.keypedia.com/companies/shanghai-henlius-biopharmaceuticals-co-ltd/27f2ead3-2366-4479-aa2e-d9895581080b)
- [Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory)](https://www.keypedia.com/companies/daewoong-pharmaceutical-co-ltd-hyangnam-factory/2f9e6a6a-9f69-4377-b1ef-5500338ce477)
- [Advanced Accelerator Applications (Italy) srl](https://www.keypedia.com/companies/advanced-accelerator-applications-italy-srl/09ac059c-6735-4082-8674-a88476dbdbc6)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [BioMarin International Limited](https://www.keypedia.com/companies/biomarin-international-limited/dbd5911b-3dec-4a03-a980-1e45a5f973a4)

## Related Officers

- [Supervisory Consumer Safety Officer, China Office](https://www.keypedia.com/people/marcus-a-ray/d394d757-5569-4697-bec1-c24113e29d6f)
- [Suzanne N. Vallez](https://www.keypedia.com/people/suzanne-n-vallez/7c16e0f4-c0b1-4f50-adfa-b1dc534694cd)
- [Cynthia Jim](https://www.keypedia.com/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)